| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/24/2003 | US20030140372 Genes for desaturases to alter lipid profiles in corn |
| 07/24/2003 | US20030140370 Fungal glyoxal oxidases |
| 07/24/2003 | US20030140369 Nucleotide sequences coding proteins for improving disease resistance or tolerance in crop plants |
| 07/24/2003 | US20030140368 Plant defensins |
| 07/24/2003 | US20030140366 Regulation of quinolate phosphoribosyl transferase expression |
| 07/24/2003 | US20030140365 Method of improving crop yields |
| 07/24/2003 | US20030140364 Transformation vector which comprises regulatory sequences for expressing trangenes in plants; disease resistant plants |
| 07/24/2003 | US20030140363 Expression vector comprising hydrolase regulatory sequences, matrix attachment region (MAR) and transcriptional enhancer for use as gene transfer tools |
| 07/24/2003 | US20030140362 Transgenic rodent implanted with virally infected cells and capable of propagating/replicating virus for detection and monitoring effectiveness of viricides such as antisense agents, lamivudine and interferons |
| 07/24/2003 | US20030140361 CCR6 chemokine receptor disruptions, compositions and methods relating thereto |
| 07/24/2003 | US20030140360 Transgenic mammals and reagents for improving long-term memory |
| 07/24/2003 | US20030140358 Transgenic mammal coding serine protease inhibitor which is expressed in mammary gland tissue and products for treating immunosuppression disorders and angioedema |
| 07/24/2003 | US20030140357 Transgenic mammal coding cholesteryl ester transfer protein and exhibiting atherosclerotic phenotype for use in treatment and diagnosis of cardiovascular and hypertensive disorders |
| 07/24/2003 | US20030140355 Expression vector containing lectin gene regulation site of mud loach |
| 07/24/2003 | US20030140354 Calcium/calmodulin-dependent protein kinase peptide for treatment of arteriosclerosis and psoriasis; antiinflammatory/anticarcinogeneic agents |
| 07/24/2003 | US20030140024 Method for encrypting and decrypting information using rule-based templates embedded with synthetic gene sequences |
| 07/24/2003 | US20030139889 Resistance circuit stabilization and pulse duration control systems for electroporation instruments |
| 07/24/2003 | US20030139590 Comprises nucleotide sequences coding orphan receptor 25 for detecting modulators of platelet activating factor (PAF) activity; antiinflammatory agents; gene/translation inhibition; drug screening |
| 07/24/2003 | US20030139587 Novel human proteins and polynucleotides encoding the same |
| 07/24/2003 | US20030139585 Oligonucleotide derivatives which are at least partly double-stranded and which have a 2'5'-linked oligonucleotide residue on at least one 3' end; use in formulating pharmaceutical for tumor therapy, infectious diseases |
| 07/24/2003 | US20030139584 Tumor necrosis factor Receptor-Associated Factor (TRAF) protein-interacting hereditary multiple extoses (TREX) for use in the diagnosis and treatment of cancer and autoimmune disorders; antitummor agents |
| 07/24/2003 | US20030139581 Protocadherin materials and methods |
| 07/24/2003 | US20030139576 Cell growth factor for stimulating proliferation/diffrentiation of chrondrocytes and treatment of bone disorders; anticarcinogenic/antiinflammatory agents |
| 07/24/2003 | US20030139574 Active hedgehog protein conjugate |
| 07/24/2003 | US20030139573 Lipid binding protein 3 |
| 07/24/2003 | US20030139572 Novel compounds |
| 07/24/2003 | US20030139365 Expression and export of angiogenesis inhibitors as immunofusins |
| 07/24/2003 | US20030139364 Methods and products for enhancing immune responses using imidazoquinoline compounds |
| 07/24/2003 | US20030139363 Methods and compositions for RNAi mediated inhibition of viral gene expression in mammals |
| 07/24/2003 | US20030139361 Organ grafting; antiinflammatory agents, autoimmune disease |
| 07/24/2003 | US20030139360 Prevention gene expression; genetic engineering |
| 07/24/2003 | US20030139359 Hybrid nucleic acids; prevent gene expression in tissue |
| 07/24/2003 | US20030139358 Anticancer agents; genetic engineering |
| 07/24/2003 | US20030139341 Regulation of human lgr4-like g protein -coupled receptor |
| 07/24/2003 | US20030139330 Transcription factors containing two potential dna binding motifs |
| 07/24/2003 | US20030139329 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/24/2003 | US20030138972 Monoclonal antibodies specific PHF-TAU, hybridomas secreting them, antigen recognition by these antibodies and their applications |
| 07/24/2003 | US20030138956 Improving transfer of plasmids/nucleotide sequences into escherichia |
| 07/24/2003 | US20030138955 Delivering nucleotide sequences coding myogenin protein for improving angiogenesis and/or neovascularisation; skin grafting; tissue engineering; wound healing agents; gene therapy |
| 07/24/2003 | US20030138954 Self-inactivating plasmid/vector; gene therapy; treating hematological disorders; anticarcinogenic agents |
| 07/24/2003 | US20030138953 Method for the generation of 3' RNA fragments and N-terminally truncated polypeptides |
| 07/24/2003 | US20030138952 Antisense modulation of PCTAIRE protein kinase 1 expression |
| 07/24/2003 | US20030138951 Conversion of liver stem and progenitor cells to pancreatic functional cells |
| 07/24/2003 | US20030138948 Pluripotent pancreatic tissue for generating differentiated islets of langerhans; drug screening; regeneration medicine; antidiabetic agents |
| 07/24/2003 | US20030138946 Genetically engineered major histocompatibiity complex antigen presenting cells for activating CD8 lymphocytes and producing cytokines and becoming cytotoxic; antitumor agents |
| 07/24/2003 | US20030138937 Genetically engineered escherichia with reduced DNA complement for use as expression vector in efficient production of important cell products such as riboflavin, lysine and glutamic acid; increased homologous recombination |
| 07/24/2003 | US20030138932 Comprises enzymatic glycoproteins for use as antitumor/antiproliferative agents; enzyme inhibitors; drug screening |
| 07/24/2003 | US20030138931 Hydrolase polypeptide for dephosphorylating mitogen activated kinases (MAP-kinase); antiapoptosis; antiproliferative agents |
| 07/24/2003 | US20030138927 Nucleic acid molecules encoding enzymes having fructosyl polymerase activity |
| 07/24/2003 | US20030138926 Novel polynucleotides and polypeptides encoded thereby |
| 07/24/2003 | US20030138925 Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease |
| 07/24/2003 | US20030138921 Recombinantly producing levodione reductase |
| 07/24/2003 | US20030138918 Methods for producing L-amino acids |
| 07/24/2003 | US20030138917 Cornyform bacterium polynucleotide coding enzyme with glucose 6-phosphate dehydrogenase activity for increasing biosynthesis of lysine; animal feeds |
| 07/24/2003 | US20030138914 Factor X deletion mutants and analogues thereof |
| 07/24/2003 | US20030138911 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 07/24/2003 | US20030138909 Methanotrophic carbon metabolism pathway genes and enzymes |
| 07/24/2003 | US20030138908 Expression vectors containing hot spot for increased recombinant protein expression in transfected cells |
| 07/24/2003 | US20030138895 Drug metabolizing enzymes |
| 07/24/2003 | US20030138893 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/24/2003 | US20030138892 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/24/2003 | US20030138891 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/24/2003 | US20030138889 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/24/2003 | US20030138888 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/24/2003 | US20030138887 For release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis |
| 07/24/2003 | US20030138886 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/24/2003 | US20030138885 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/24/2003 | US20030138884 APRIL- a novel protein with growth effects |
| 07/24/2003 | US20030138883 For release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis |
| 07/24/2003 | US20030138881 Novel co-stimulatory molecules |
| 07/24/2003 | US20030138879 Phosphopantetheinyl transferases and uses thereof |
| 07/24/2003 | US20030138872 Contacting a solution containing homocysteine and/or cystathionine with cystathionine beta-synthase, L-serine, cystathionine beta-lyase to catalyze cyclical conversion of homocysteine to cystathionine and then vice-versa conversion |
| 07/24/2003 | US20030138864 Comparing expression levels of genes or proteins in human tissue or cells from normal and tumor origin, selecting enzyme of which mRNA or protein levels in tumor tissue are higher by two-fold as compared to normal cells or tissue |
| 07/24/2003 | US20030138854 Method for determining BAGE expression |
| 07/24/2003 | US20030138850 Selecting for antibody-antigen interactions in bacteria cells by employing a protein fragment complementation assay |
| 07/24/2003 | US20030138848 3D structure of polypeptides containing a TPR-structure motif with chaperone-binding function, crystals thereof and compounds for inhibition of said polypeptides |
| 07/24/2003 | US20030138844 Antibodies binding a gamma carboxyglutamic acid displaying epitope |
| 07/24/2003 | US20030138843 Generating/measuring improved polypeptide solubility in vitro/in situ using reporter molecule and mutagenesis |
| 07/24/2003 | US20030138841 Library of novel ''unnatural'' natural products |
| 07/24/2003 | US20030138839 Polypeptide comprising ubiquitination regulating domain; antiproliferative agents; neuroprotectants; cancer diagnosis |
| 07/24/2003 | US20030138837 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 07/24/2003 | US20030138836 Detecting modulators of a silencing mediator for retinoic acid receptor; relieving suppression of steroid/thyroid hormone receptor activity; GAL4 DNA binding domains |
| 07/24/2003 | US20030138833 Psoriasin expression by breast epithelial cells |
| 07/24/2003 | US20030138828 Compositions and methods of selective nucleic acid isolation |
| 07/24/2003 | US20030138825 Synthesis of hybrid polynucleotide molecules using single-stranded polynucleotide molecules |
| 07/24/2003 | US20030138824 Method and kit for analyzing target nucleic acid fragment |
| 07/24/2003 | US20030138820 Sugar transport protein for use in diagnosis and treatment of diabetes, hypertriglyceridemia and hyperinsulinemia |
| 07/24/2003 | US20030138818 G-protein coupled receptors |
| 07/24/2003 | US20030138815 Cyclic adenosine monophosphate (cAMP); drug screening; bronchodilators; antiinflammatory agents; immunomodulators; antiallergens; bioassays |
| 07/24/2003 | US20030138810 High throughput method for discovery of gene clusters |
| 07/24/2003 | US20030138809 Sequencing DNA using polymerase, fluorescence, chemiluminescence, thermopile, thermistor and refractive index measurements; microcalorimetric detection |
| 07/24/2003 | US20030138808 Polypeptides wherein epitopes correspond to proteosome cleavage product of tyrosinase and major histocompatability complex; vaccine |
| 07/24/2003 | US20030138805 Thermostable chimeric nucleic acid polymerases and uses thereof |
| 07/24/2003 | US20030138803 Identification and use of molecules implicated in pain |
| 07/24/2003 | US20030138802 Glycosyltransferases (SMAP-1); transmembrane traps (TMT); fetal hepatocytes for regulation of apoptosis and inflammatory reactions; alzheimer's treatment |
| 07/24/2003 | US20030138800 Replicating preferential nucleotide sequences using endonucleases and polymerases; nicking agent recognition sequence (NARS); nicking endonuclease recognition sequence (NERS) |
| 07/24/2003 | US20030138796 Method for synthesising and immobilising nucleic acids on a silanized solid support |
| 07/24/2003 | US20030138793 Kit for identifying the origin of tumors in prostate, breast, colorectal, lung, ovarian, gastroesophageal, pancreatic, liver, kidney or bladder cells by way of probes for analyzing marker gene expression |
| 07/24/2003 | US20030138784 Linear and circular expression elements |
| 07/24/2003 | US20030138782 Computer-directed assembly of a polynucleotide encoding a target polypeptide |